Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05913206 · ClinicalTrials.gov registry record · NA
Understanding Factors in Decision Making for Children With Medical Complexity
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 831
- Enrollment target
NCT05913206: Completed NA study, sponsored by University of Utah.
NCT05913206 is a NA study that has completed, run by University of Utah. The registered enrollment target is 831 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05913206, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 831 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare different strategies to communicate around potential risks and benefits related to treatment decision making in parents/adult caregivers of children with medical complexity. The objective of this study is to identify the most effective ways to communicate decision-related risks and benefits to improve the quality of caregiver decision making for children with medical complexity. Participants will view a video of a simulated clinic visit and related medical information and complete a survey about their experiences. Researchers will compare participant survey responses to see if decision quality changes based on the information reviewed by the participant.
Primary Outcome
Differences in decision readiness between arms as measured by the validated PrepDM survey measure. The PrepDM is a 10-item (1 to 5 scale) validated survey measure that evaluates a patient's perceived readiness to make a decision with their healthcare provider. The composite score is a mean of all items converted to a scale of 0-100 with higher scores indicating greater decision readiness. PrepDM is widely used to evaluate the effectiveness of decision aids.
Interventions
- BEHAVIORAL Ambiguity
- BEHAVIORAL Complexity
- BEHAVIORAL Normalizing language
- BEHAVIORAL Narrative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 831 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2024-08-29 |
| Phase | NA |
What the finished NCT05913206 record still lists
NCT05913206 is an interventional study that assigns participants to a tested intervention. The registered 831 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 4 interventions - of which Ambiguity is the first listed.
NCT05913206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05913206 about?
NCT05913206 is a clinical study titled "Understanding Factors in Decision Making for Children With Medical Complexity". The goal of this clinical trial is to compare different strategies to communicate around potential risks and benefits related to treatment decision making in parents/adult caregivers of children with medical complexity. The objective of this study is to identify the most effective ways to communicat...
What is the current status of trial NCT05913206?
This trial is currently completed. It is a NA study. The enrollment target is 831 participants. The study started on 2023-06-29. Estimated completion is 2024-08-29.
What interventions are being tested in trial NCT05913206?
The interventions under investigation include: Ambiguity (BEHAVIORAL), Complexity (BEHAVIORAL), Normalizing language (BEHAVIORAL), Narrative (BEHAVIORAL).
Who is sponsoring clinical trial NCT05913206?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05913206's enrollment target sits among peer trials
831 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI